New York City, NY -- (SBWIRE) -- 08/26/2013 -- StockMarketIntel.com issues a special report on the following stocks: GRID PETROLEUM CORP (OTCMKTS:GRPR), Fuelstream Inc (OTCMKTS:FLST), SafeStitch Medical Inc (OTCBB:SFES), NanoViricides Inc (OTCBB:NNVC)
GRID PETROLEUM CORP (OTCMKTS:GRPR) declined -20%, trading on 145.49 million shares, to end the trade at $0.0012. The stock changed hands in a range of $0.0012 to $0.0018, bringing its market capitalization to about $1.05 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.0001 and was moved to the maximum level of $0.013. Grid Petroleum Corp. (GRPR):: The Board of Directors are pleased to announcing that Grid Petroleum has entered into negotiations with the leaseholders of approximately two thousand acres of land in Duval County, Texas for the purpose of exploration and Oil and Gas development.
Has GRPR Found The Bottom And Ready To Gain Momentum? Find Out Here
Fuelstream Inc (OTCMKTS:FLST) added 58.33%, to complete the trading session at $0.190, with a total volume of 1.21million shares. The stock, on average, trades on a volume of 863,376 shares. It floated in a range of $0.12 to $0.20 during the last trading session, with a beta value of 2.33. Its market capitalization now moved to about $3.74 million. In the past 52 weeks, the share price has not declined below $0.02 and above $3.25. Fuelstream Inc (FLST) announced that it has entered into an agreement with Skyplan, based in Calgary, Canada, to provide flight planning, weather support and ground support, as well as permit processing and traffic rights requests.
Will FLST Continue To Move Higher? Find Out Here
SafeStitch Medical Inc (OTCBB:SFES) added 4.73% and was in a range of $1.45-$1.57 before closing at $1.55. The stock completed the day with a total volume of 123,877 shares, versus an average volume of 133,361 shares. The share price hit its 52-week low of $0.21 and $1.57 was the best price. SafeStitch Medical, Inc., a developmental stage medical device company, engages in the development of medical devices in the United States. Its medical devices manipulate tissues for endoscopic and minimally invasive surgery in the treatment of obesity, gastroesophageal reflux disease (GERD), Barretts esophagus, esophageal obstructions, upper gastrointestinal bleeding, hernia formation, and other intraperitoneal abnormalities.
Why Should Investors Buy SFES After The Recent Gain? Just Go Here and Find Out
NanoViricides Inc (OTCBB:NNVC) added 3.48%, bringing its market capitalization around $191.48 million. The share price, after opening at $1.15, made a high of $1.21 and hovered above $1.15 to end the day at $1.19. The total number of shares that changed hands during the session was 156,464 shares, as compared to average trading volume of 390,854 shares. NanoViricides, Inc. (OTC BB: NNVC) (the "Company") reported today that the renovation of the facility in Shelton, CT, to build its new clinical scale cGMP production plant is progressing on schedule. The Company reports that its project for enabling clinical scale drug product cGMP capability is now in the Construction phase. Design, engineering, and architecture for this facility were completed at the end of June, 2013. Subcontractors were retained at the end of June as well.
What was the Moving Force behind NNVC on Bullish Run? Read This Research Report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)